ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies.
Saved in:
| Title: | ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. |
|---|---|
| Authors: | Low JS; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.; Institute of Microbiology, ETH Zürich, 8093 Zurich, Switzerland., Jerak J; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.; Institute of Microbiology, ETH Zürich, 8093 Zurich, Switzerland., Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., McCallum M; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Pinto D; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland., Cassotta A; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland., Foglierini M; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland., Mele F; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland., Abdelnabi R; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium., Weynand B; KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, B-3000 Leuven, Belgium., Noack J; Vir Biotechnology, San Francisco, CA 94158, USA., Montiel-Ruiz M; Vir Biotechnology, San Francisco, CA 94158, USA., Bianchi S; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland., Benigni F; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland., Sprugasci N; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland., Joshi A; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Bowen JE; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Stewart C; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Rexhepaj M; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA., Walls AC; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Jarrossay D; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland., Morone D; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland., Paparoditis P; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland., Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland., Ferrari P; Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland.; Department of Internal Medicine, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.; Prince of Wales Hospital Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia., Ceschi A; Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland.; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.; Clinical Trial Unit, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland., Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium.; Global Virus Network, Baltimore, MD 21201, USA., Purcell LA; Vir Biotechnology, San Francisco, CA 94158, USA., Snell G; Vir Biotechnology, San Francisco, CA 94158, USA., Corti D; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland., Lanzavecchia A; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland.; National Institute of Molecular Genetics, 20122 Milano, Italy., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Sallusto F; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.; Institute of Microbiology, ETH Zürich, 8093 Zurich, Switzerland. |
| Source: | Science (New York, N.Y.) [Science] 2022 Aug 12; Vol. 377 (6607), pp. 735-742. Date of Electronic Publication: 2022 Jul 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35857703 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Low+JS%22">Low JS</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.; Institute of Microbiology, ETH Zürich, 8093 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jerak+J%22">Jerak J</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.; Institute of Microbiology, ETH Zürich, 8093 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tortorici+MA%22">Tortorici MA</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22McCallum+M%22">McCallum M</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Pinto+D%22">Pinto D</searchLink>; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cassotta+A%22">Cassotta A</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Foglierini+M%22">Foglierini M</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mele+F%22">Mele F</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Abdelnabi+R%22">Abdelnabi R</searchLink>; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Weynand+B%22">Weynand B</searchLink>; KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, B-3000 Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Noack+J%22">Noack J</searchLink>; Vir Biotechnology, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Montiel-Ruiz+M%22">Montiel-Ruiz M</searchLink>; Vir Biotechnology, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Bianchi+S%22">Bianchi S</searchLink>; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Benigni+F%22">Benigni F</searchLink>; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sprugasci+N%22">Sprugasci N</searchLink>; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Joshi+A%22">Joshi A</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Bowen+JE%22">Bowen JE</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Stewart+C%22">Stewart C</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Rexhepaj+M%22">Rexhepaj M</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Walls+AC%22">Walls AC</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Howard Hughes Medical Institute, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Jarrossay+D%22">Jarrossay D</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Morone+D%22">Morone D</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Paparoditis+P%22">Paparoditis P</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Garzoni+C%22">Garzoni C</searchLink>; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ferrari+P%22">Ferrari P</searchLink>; Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland.; Department of Internal Medicine, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.; Prince of Wales Hospital Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia.<br /><searchLink fieldCode="AU" term="%22Ceschi+A%22">Ceschi A</searchLink>; Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland.; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.; Clinical Trial Unit, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Neyts+J%22">Neyts J</searchLink>; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium.; Global Virus Network, Baltimore, MD 21201, USA.<br /><searchLink fieldCode="AU" term="%22Purcell+LA%22">Purcell LA</searchLink>; Vir Biotechnology, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Snell+G%22">Snell G</searchLink>; Vir Biotechnology, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Corti+D%22">Corti D</searchLink>; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lanzavecchia+A%22">Lanzavecchia A</searchLink>; Humabs BioMed SA (subsidiary of Vir Biotechnology), 6500 Bellinzona, Switzerland.; National Institute of Molecular Genetics, 20122 Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Veesler+D%22">Veesler D</searchLink>; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Howard Hughes Medical Institute, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Sallusto+F%22">Sallusto F</searchLink>; Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.; Institute of Microbiology, ETH Zürich, 8093 Zurich, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220404511%22">Science (New York, N.Y.)</searchLink> [Science] 2022 Aug 12; Vol. 377 (6607), pp. 735-742. <i>Date of Electronic Publication: </i>2022 Jul 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0404511 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1095-9203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200368075%22">00368075 </searchLink><i>NLM ISO Abbreviation: </i>Science <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35857703 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1126/science.abq2679 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 735 Titles: – TitleFull: ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Low JS – PersonEntity: Name: NameFull: Jerak J – PersonEntity: Name: NameFull: Tortorici MA – PersonEntity: Name: NameFull: McCallum M – PersonEntity: Name: NameFull: Pinto D – PersonEntity: Name: NameFull: Cassotta A – PersonEntity: Name: NameFull: Foglierini M – PersonEntity: Name: NameFull: Mele F – PersonEntity: Name: NameFull: Abdelnabi R – PersonEntity: Name: NameFull: Weynand B – PersonEntity: Name: NameFull: Noack J – PersonEntity: Name: NameFull: Montiel-Ruiz M – PersonEntity: Name: NameFull: Bianchi S – PersonEntity: Name: NameFull: Benigni F – PersonEntity: Name: NameFull: Sprugasci N – PersonEntity: Name: NameFull: Joshi A – PersonEntity: Name: NameFull: Bowen JE – PersonEntity: Name: NameFull: Stewart C – PersonEntity: Name: NameFull: Rexhepaj M – PersonEntity: Name: NameFull: Walls AC – PersonEntity: Name: NameFull: Jarrossay D – PersonEntity: Name: NameFull: Morone D – PersonEntity: Name: NameFull: Paparoditis P – PersonEntity: Name: NameFull: Garzoni C – PersonEntity: Name: NameFull: Ferrari P – PersonEntity: Name: NameFull: Ceschi A – PersonEntity: Name: NameFull: Neyts J – PersonEntity: Name: NameFull: Purcell LA – PersonEntity: Name: NameFull: Snell G – PersonEntity: Name: NameFull: Corti D – PersonEntity: Name: NameFull: Lanzavecchia A – PersonEntity: Name: NameFull: Veesler D – PersonEntity: Name: NameFull: Sallusto F IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 08 Text: 2022 Aug 12 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1095-9203 Numbering: – Type: volume Value: 377 – Type: issue Value: 6607 Titles: – TitleFull: Science (New York, N.Y.) Type: main |
| ResultId | 1 |